Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Oncology

Response of Cutaneous Metastases from Breast Cancer to Capecitabine

Submit a Paper


Clinical Medicine Insights: Oncology 2008:2 415-418

Published on 18 Apr 2008


Further metadata provided in PDF



Sign up for Email Alerts and keep in touch with Clinical Medicine Insights: Oncology journal news, updates, events and articles

Abstract

Excluding malignant melanoma, breast cancer has the highest incidence of cutaneous metastasis compared to any other solid malignancy. Up to 24% of patients with metastatic breast cancer are expected to have metastasis to the skin. Clinical trials testing various chemotherapeutic regiments for metastatic breast cancer generally do not report the success or failure rates of their regiments in relation to patients with metastasis to the skin. We report here 2 patients with cutaneous metastatic breast cancer who experiences dramatic and durable responses to single agent oral capecitabine. In addition we provide a brief review of the literature regarding the presentation, prognosis and treatment of cutaneous metastatic breast cancer with particular attention to local treatment modalities available.



Downloads

PDF  (895.89 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML

PMC HTML


Sharing


What Your Colleagues Say About Clinical Medicine Insights: Oncology
Our experience publishing in Clinical Medicine Insights: Oncology was the easiest and most user-friendly interface we have encountered.  The staff were very attentive to us and kept us posted at every step of the process.  It was rewarding to have our article appear in press within weeks, compared to months at other journals.
Dr Darrell Ellsworth (Windber Research Institute, Windber, PA, USA)
More Testimonials

Quick Links


New article and journal news notification services
Email Alerts RSS Feeds
Facebook Google+ Twitter
Pinterest Tumblr YouTube